ArticleRheumatology advances in practice2023

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD).

Pawel Mielnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.